Drug shortage
Clonazepam Tablet · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Apr 7, 2025
Key facts
| Generic name | Clonazepam Tablet |
|---|---|
| Proprietary name | Clonazepam |
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) |
| Dosage form | Tablet |
| Strength | .5 mg |
| Status | Current |
| Therapeutic category | Neurology Pediatric Psychiatry |
| Package NDCs | 0093-0832-05 |
| First posted | Mar 10, 2023 |
| Last updated | Apr 7, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: